Red light treatment for nearsightedness: a new hope?

NCT ID NCT07186088

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether repeated low-intensity red light can treat myopia (nearsightedness) in adults aged 18 to 35. Thirty participants will use a red light device 1 to 3 times daily. Researchers will measure changes in eye length and prescription strength to see if the treatment is safe and effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

low-intensity red light

What this could lead to

If it works, this could offer a non-invasive way to control or reduce myopia in adults, potentially reducing dependence on glasses or contacts.

What could go wrong

This is a very small early study (30 people) with no control group, so results may not be reliable. The long-term safety of repeated red light exposure is unknown.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tianjin Medical University Eye Hospital

    Tianjin, Tianjin Municipality, 120120, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••